Mitsubishi UFJ Financial Group expected to offer 'Vaccine Bonds' to Japanese investors

Restricted Access Library

The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.

Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.

The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.

The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.

Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.

Children in the world's poorest countries could benefit from a lifetime of protection from vaccine-preventable diseases thanks to the proposed sale next month of Vaccine Bonds to Japanese retail investors by Mitsubishi UFJ Financial Group

THIS DOCUMENT IS NOT AN OFFER FOR THE SALE OF SECURITIES. THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES

6 April 2009 - Children in the world's poorest countries could benefit from a lifetime of protection from vaccine-preventable diseases thanks to the proposed sale next month of Vaccine Bonds to Japanese retail investors by Mitsubishi UFJ Financial Group (MUFG) - The Bank of Tokyo-Mitsubishi UFJ, Ltd. (President: Katsunori Nagayasu), Mitsubishi UFJ Trust and Banking Corporation (President & CEO: Kinya Okauchi) and Mitsubishi UFJ Securities Co., Ltd. (President & CEO: Fumiyuki Akikusa).

Mitsubishi UFJ Securities Co., Ltd. will arrange the contemplated uridashi transaction and distribute the Vaccine Bonds, whilst The Bank of Tokyo-Mitsubishi UFJ, Ltd. and Mitsubishi UFJ Trust and Banking Corporation will distribute the Vaccine Bonds by acting as financial intermediaries for Mitsubishi UFJ Securities Co., Ltd.

The Expected Products:

Issuer: International Finance Facility for Immunisation Company (IFFIm)
Bonds: USD and AUD Denominated Fixed Rate Notes
Maturity: 3 years
Denomination: USD/AUD 1,000
Offering period: 19 May 2009 (Tue) ~ 27 May 2009 (Wed)

IFFIm's support to GAVI

Vaccine Bonds are issued by the International Finance Facility for Immunisation (IFFIm) to support the GAVI Alliance, a public-private partnership working to immunise children against vaccine-preventable diseases and strengthen health systems in 70 of the world's poorest countries.

With the World Bank acting as its treasury manager, IFFIm has raised more than US$1.6 billion to support GAVI immunisation programmes since 2006. IFFIm has triple-A rating due to the support of seven sovereign countries which have made legally binding commitments to contribute US$5.3 billion over 20 years -- France, Italy, Norway, South Africa, Spain, Sweden and the United Kingdom.

A rewarding investment

We, the MUFG Group, believe we can make a contribution to society by arranging these Vaccine Bonds and also offer an opportunity to a wide variety of clients to contribute to society whilst investing.

Spokesperson, MUFG

"We, the MUFG Group, believe we can make a contribution to society by arranging these Vaccine Bonds and also offer an opportunity to a wide variety of clients to contribute to society whilst investing," said a spokesperson for MUFG.

"We recognize the role that we ought to play in society as a comprehensive financial services provider and intend to contribute in realising a sustainable society."

"This is an investment opportunity with an ethical bonus. The money invested will be used for GAVI's immunisation programmes which will set up millions of the world's poorest children for a healthy life. What could be a more rewarding investment than that?" said Dr Julian Lob-Levyt, CEO of the GAVI Alliance.

Preventable diseases

Every year some 27 million infants miss out on vaccination against the most common childhood diseases. As a result, between 2 and 3 million children die annually from easily preventable diseases.

Many more fall sick, miss school and become part of the vicious cycle that links poor health to continued poverty in adulthood.

With funds that IFFIm raises in the international capital markets and which will be disbursed until 2015 to the GAVI Alliance, it is estimated that an additional 500 million children will be vaccinated against preventable diseases. To achieve this goal, IFFIm is expected to provide a total of US$4 billion to the GAVI Alliance.

About IFFIm

International Finance Facility for Immunisation Company (IFFIm) is a multilateral development institution created to accelerate the availability of predictable, long-term funds for health and immunisation programmes through the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunisation) in 70 of the poorest countries around the world.

IFFIm was created as a development financing tool to help the international community achieve the Millennium Development Goals. IFFIm's financial base consists of legally binding grants payments from its sovereign sponsors (France, Italy, Norway, South Africa, Spain, Sweden and the UK), on the basis of which IFFIm's is rated AAA/Aaa/AAA (Fitch/Moody's/S&P). The World Bank is the Treasury Manager for IFFIm. IFFIm was established as a charity with the Charity Commission for England and Wales and is registered in England and Wales as a company limited by guarantee with number 5857343 and as a charity with number 1115413.

About the GAVI Alliance

The GAVI Alliance is a public-private partnership that aims to immunise children and strengthen health systems in the world's poorest countries. It brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, NGOs, the Bill & Melinda Gates Foundation and private philanthropists. GAVI provides vaccines against diphtheria, tetanus, pertussis combined with haemophilus influenzae type b and hepatitis B as so-called pentavalent (five antigens in one vaccine) as well as vaccines against measles, yellow fever, pneumococcal diseases (pneumonia and meningitis) and rotavirus (diarrhoea).

About the World Bank

The World Bank is a global development cooperative owned by 185 member countries. Its purpose is to help its members achieve equitable and sustainable economic growth in their national economies and to find effective solutions to pressing regional and global problems in economic development and environmental sustainability. The goal is to help overcome poverty and improve standards of living for people worldwide. The International Bank for Reconstruction and Development (IBRD), rated Aaa/AAA (Moody's/S&P), is the oldest and largest entity in the World Bank Group and provides funding, risk management tools and credit enhancement to sovereigns. To fund this activity, IBRD has been issuing debt securities in the international capital markets for 60 years. The World Bank is also the Treasury Manager for IFFIm. In that capacity, the World Bank, as IFFIm's agent, manages IFFIm's finances according to prudent policies and standards. This includes IFFIm's funding strategy and its implementation in the capital markets, rating agency and investor outreach, hedging transactions and investment management. The World Bank also coordinates with IFFIm's donors and manages their pledges and payments as well as IFFIm's disbursements for immunisation and health programmes through the GAVI Alliance.

About Mitsubishi UFJ Financial Group (MUFG)

MUFG is one of the world's leading financial groups, with total assets of more than JPY190 trillion (approximately US$1.8 trillion) as of March 31, 2008. MUFG's services include commercial banking, trust banking, securities, credit cards, consumer finance, asset management and leasing. The Group's operating companies include The Bank of Tokyo-Mitsubishi UFJ, Japan's largest commercial bank, Mitsubishi UFJ Trust and Banking Corporation, Japan's leading trust bank, and Mitsubishi UFJ Securities, one of Japan's largest securities firms. Click for more information about MUFG 

The securities referred to in this document have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under the securities legislation of any state of the United States, and may not be offered or sold in the United States, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. IFFIm does not presently intend to make a public offer of securities in the United States or to register any securities under the Securities Act. The securities referred to in this document will only be offered or sold outside the United States in offshore transactions in reliance on Regulation S under the Securities Act.

Media contacts
Yoshiyuki Arima

Yoshiyuki Arima
World Bank
Tel: +81 3 3597 6650

close icon

modal window here